Skip to main content

Table 2 Procedure-related characteristics

From: Do ultrathin strut bare-metal stents with passive coating improve efficacy in large coronary arteries? Insights from the randomized, multicenter BASKET-PROVE trials

 

Silicon carbide-coated BMS

Uncoated cobalt-chromium BMS

P-value

Patients, no.

761

765

 

Treated segments, no.

962

1117

 

Treated vessels

 Left main artery (protected)

3 (0.4)

9 (1.2)

0.15

 Left anterior descending artery

491 (64.5)

496 (64.8)

0.94

 Left circumflex artery

252 (33.1)

279 (36.5)

0.19

 Right coronary artery

394 (51.8)

414 (54.1)

0.39

Complexity of CADa

 Multivessel disease

299 (39.3)

327 (42.7)

0.19

 Bifurcational lesion

45 (5.9)

68 (8.9)

0.033

 Chronic total occlusion

26 (3.4)

39 (5.1)

0.13

 Stent <3.0 mm

20 (2.6)

38 (5.0)

0.024

 GPIIb/IIIa blocker use

93 (12.2)

168 (22.0)

<0.001

Procedural characteristicsa, b

 Segments per patient, no.

1.3 ± 0.5

1.5 ± 0.8

<0.001

 Stents per patient, no.

1.5 ± 0.8

1.7 ± 1.1

<0.001

 Total stent length, mm

25.1 ± 15.7

31.2 ± 22.5

<0.001

 Stent length per lesion, mm

19.7 ± 7.9

21.1 ± 9.6

0.017

 Maximum deployment pressure, mmHg

14.7 ± 3.4

15.1 ± 3.3

0.003

 Staged procedure

45 (5.9)

33 (4.3)

0.20

 Lesions with angiographic success, no.

917 (95.3)

1080 (96.7)

0.14

  1. No. are counts (%), unless otherwise indicated. BMS bare-metal stent, CAD coronary artery disease
  2. aMissing for 1 patient in the UC-BMS group
  3. bPlus-minus values are mean ± SD